Anticoagulation during extracorporeal life support

Progress in Pediatric Cardiology

Volumn 21, Issue 1, 2005, Pages 81-85

  Lequier, Laurance ^a,b   Chan, Anthony ^c  

^a STOLLERY CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulation; Extracorporeal life support; Extracorporeal membrane oxygenation; Heparin; Thrombosis

Indexed keywords

HEPARIN;

ANTICOAGULATION; BLEEDING; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SURFACE PROPERTY; THROMBOSIS;

EID: 28844481865     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2005.09.010     Document Type: Article

References (62)

1. L. Lequier Extracorporeal life support in pediatric and neonatal critical care: a review J Intensive Care Med. 19 2004 243 258
2. Extracorporeal Life Support Organization. ECLS Registry Report. Ann Arbor; University of Michigan; July 2005.
3. S. Wan, J.L. LeClerc, and J.L. Vincent Inflammatory response to cardiopulmonary bypass Chest 112 1997 676 692
4. F.W. Bowen, and H.L. Edmunds Jr. Coagulation, anticoagulation and the interaction of blood and artificial surfaces J.B. Zwischenberger R.H. Steinhorn R.H. Bartlett ECMO: extracorporeal cardiopulmonary support in critical care 2nd Ed. 2000 ELSO Ann Arbor, Mich 67 96
5. J.D. Fortenberry, V. Bhardwaj, and P. Niemer Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation J Pediatr 128 1996 670 678
6. B. Furie, and B.C. Furie Molecular and cellular biology of blood coagulation N Engl J Med 326 1992 800 806
7. H. Valhonart, R.D. Swinford, and J.R. Ingelfinger Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation ASAIO J 45 1999 113 114
8. F.B. Plotz, W. van Oeveren, and R.H. Bartlett Blood activation during neonatal extracorporeal life support J Thorac Cardiovasc Surg 105 1993 823 832
9. A.R. Webb, M.G. Mythen, and D. Jacobsen Maintaining blood flow in the extracorporeal circuit: hemostasis and anticoagulation Intensive Care Med 21 1995 84 93
10. B. Urlesberger, G. Zobel, and W. Zenz Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants J Pediatr 129 1996 264 268
11. M.L. McManus, S.V. Kevy, and L.K. Bower Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation J Pediatr 126 1995 900 904
12. H.J. Dalton Outcome following pediatric ECMO J.B. Zwischenberger R.H. Steinhorn R.H. Bartlett ECMO: extracorporeal cardiopulmonary support in critical care 2nd Ed. 2000 ELSO Ann Arbor, Mich 481 493
13. J.W. Watson, D.N. Brown, and K.P. Lally Complications of extracorporeal membrane oxygenation in neonates South Med J 83 1990 1262 1265
14. G.E. Havdart, and C.J. Fackler Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation Intensive Care Med 27 2001 1395 1400
15. M. Andrew, B. Paes, and M. Johnston Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1990 95 104
16. A. Stallion, B.R. Cofer, and J.A. Rafferty The significant relationship between platelet count and haemorrhagic complications on ECMO Perfusion 9 1994 265 269
17. Extracorporeal Life Support Organization Registry report 2005 (January) University of Michigan Ann Arbor
18. D. Bulas, and P. Glass Neonatal ECMO: neuroimaging and neurodevelopmental outcome Semin Perinatol 29 2005 58 65
19. B. Stiller, J. Lemmer, and W. Alexi-Meskishvili Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device Intensive Care Med 30 2004 1814 1820
20. C.D. Downard, P. Betit, R.W. Chang, J.J. Garza, J.H. Arnold, and J.M. Wilson Impact of Amicar on hemorrhagic complications of ECMO: A ten year review J Pediatr Surg 38 2003 1212 1216
21. A.K. Biswas, L. Lewis, and J.F. Sommerauer Aprotinin in the management of life-threatening bleeding during extracorporeal life support Perfusion 15 2000 211 216
22. A. Verrijckt, F. Proulx, S. Morneau, and S. Vobecky Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation J Thorac Cardiovasc Surg 127 2004 1812 1813
23. T.E. Dominguez, M. Mitchell, and S.H. Friess Use of recombinant factor UNA for refractory hemorrhage during extracorporeal membrane oxygenation Pediatr Crit Care Med 6 2005 348 351
24. M. Riccabona, M. Kuttnig-Haim, and D. Dacar Venous thrombosis in and after extracorporeal membrane oxygenation: detection and follow up by color Doppler sonography Eur Radiol 7 1997 1383 1386
25. J.B. Zwischenberger, T.T. Nguyen, and J.R. Upp Complications of neonatal extracorporeal membrane oxygenation J Thorac Cardiovasc Surg 107 1994 838 848
26. S. Westaby Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit Intensive Care Med 13 1987 89 95
27. M. Keszler, F.C. Ryckman, and J.V. McDonald A prospective multicenter randomized study of high versus low peep during extracorporeal membrane oxygenation J Pediatr 120 1992 107 113
28. M.M. Samama, L. Bara, and I. Goulin-Thibault New data on the pharmacology of heparin and low molecular weight heparin Drugs 52 1996 8 15
29. J.I. Weitz, M. Hudoba, and K Massel Clot-bound thrombin is protected from inhibition by heparin antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 1990 385 391
30. H.J. Dalton Extracorporeal life support in the new millenium: forging ahead or fading out New Horiz 7 1999 414 432
31. A. Shapiro Antithrombin deficiency in special clinical syndromes: Part I. Extracorporeal membrane oxygenation Semin Hematol 32 1995 33 36
32. M.E. Pollock, J.T. Owings, and R.C. Gosselin ATIII replacement during infant extracorporeal support Thromb Haemost 73 1995 936
33. P.J. Thureen, M. Loomis, and M. Manco-Johnson Randomized trial of albumin versus plasma for correction of ATIII deficiency in neonatal ECMO Second annual meeting of ELSO 1990 Abstract 50
34. T.P. Green, B. Isham-Schopf, and R.H. Steinhorn Whole blood activated clotting time in infants during extracorporeal membrane oxygenation Crit Care Med 18 1990 494 498
35. J.J. DeWaele, S. Van Cauwenberghe, and E. Hoste The use of activated clotting time for monitoring heparin therapy in critically ill patients Intensive Care Med 29 2003 325 328
36. A. Koster, G. Despotis, and M. Gruendel The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation Anesth Analg 95 2002 26 30
37. P.D. Raymond, M.J. Ray, S.N. Callen, and N.A. Marsh Heparin monitoring during cardiac surgery: Part 2. Calculating the overestimation of heparin by the activated clotting time Perfusion 18 2003 277 281
38. A.K. Chan, M. Leaker, and F.A. Burrows Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass Thromb Haemost 77 1997 270 277
39. C. Gruenwald, V. deSouza, A.K. Chan, and M. Andrew Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass Perfusion 15 2000 203 209
40. C. Male, M. Johnston, C. Sparling, L. Brooker, M. Andrew, and P. Massicotte The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood Clin Lab Med 19 1999 39 69
41. J.T. Owings, M.E. Pollock, R.C. Gosselin, K. Ireland, J.S. Jahr, and E.C. Larkin Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques Arch Surg 135 2000 1042 1047
42. R. Powers, J. Vilardi, and R. Allenhoff The effect of platelet transfusions on coagulation values in neonates on ECMO Am Soc Pediatr Hemat Oncol 1990 [Abstract #51]
43. D.F. Graves, J.M. Chernin, M. Kurusz, and J.B. Zwischenberger Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results Perfusion 11 1996 461 466
44. W. Muntean Coagulation and anticoagulation in extracorporeal membrane oxygenation Artif Organs 23 1999 979 983
45. S.M. Bates, and J.I. Weitz The mechanism of action of thrombin inhibitors J. Invasive Cardiol 12 2000 1 12
46. G. Young, K.E. Yonekawa, P. Nakagawa, and A.J. Nugent Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits Perfusion 19 2004 283 288
47. B. Mejak, C. Giacomuzzi, and E. Heller Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia J Extra Corpor Technol 36 2004 178 181
48. W.E. Dager, R.C. Gosselin, R. Yoshikawa, and J.T. Owings Lepirodin in heparin-induced thrombocytopenia and extracorporeal membrane oxygenation Ann Pharmacother 38 2004 598 601
49. M.W. Radomski, R.MJ. Palmer, and S. Moncada The anti-aggregating properties of vascular endothelium: interactions between prostacycline and nitric oxide Br J Pharmacol 92 1987 639 646
50. 1 during cardiopulmonary bypass in rhesus monkeys Surgery 83 1978 619 625
51. J. Jacobson Nitric oxide: platelet protectant properties during cardiopulmonary bypass/ECMO J Extra Corpor Technol 34 2002 144 147
52. G.M. Annich, J.P. Meinhardt, and K.A. Mowery Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers Crit Care Med 28 2000 915 920
53. G.M. Palatianos, C.N. Foroulis, and M.I. Vassili A prospective, double-blind study of the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit Ann Thorac Surg 76 2003 129 135
54. K. Ichinose, T. Okamoto, and H. Tanimoto Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats Artificial Organs 28 2004 993 1001
55. R. Marcolin, M. Bonbino, and A. Pesenti Venovenous ELS with heparin bonded circuits Int J Artif Organs 18 1995 624 626
56. E. Ovrum, G. Tangen, R. Oyslese, M.A. Ringdal, and R. Istad Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery J Card Surg 18 2003 140 146
57. B. Urlesberger, G. Zobel, and S. Rodl Activation of the clotting system: heparin-coated versus non-coated systems for extracorporeal circulation Int J Artif Organs 20 1997 708 712
58. E. Tayama, N. Hayashida, and K. Akasu Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system Artif Organs 24 2000 618 623
59. M. Nagaya, M. Futamura, J. Kato, N. Niimi, and S. Fukuta Application of a new anticoagulant to control hemorrhagic complications during extracorporeal membrane oxygenation J Pediatr Surg 32 1997 531 535
60. M. Skogby, L.G. Friberg, K. Adrian, and K. Mellgren Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion Scand Cardiovasc J 37 2003 222 228
61. O. Shigeta, P. Gluszko, and S.W. Downing Protection of platelets during long term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin Circulation Suppl II 1992 398 404
62. M. Glauber, J. Szefner, M. Senni, and A. Gamba Reduction of hemorrhagic complications during mechanically assisted circulation with the use of a multi- system anticoagulation protocol Artif Organs 18 1995 649 655